Alps ETF Trust · net assets $162M · 89 holdings as of May 31, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 100.0% · STIV: 0.0% · DE: 0.0%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $0 | $22.2M | $4.13M |
| Reinvestment | $0 | $0 | $0 |
| Redemptions | $7.35M | $1.44M | $0 |
| Net realized gain (non-derivative) | $1.36M | $1.88M | $1.98M |
| Net unrealized appreciation (non-derivative) | $-249 | $959K | $249K |
The three months of the reporting period, as filed; month 3 ends May 31, 2026.
| Holding | Value | % of net assets |
|---|---|---|
| Alkermes PLC EC | $7.24M | 4.48% |
| Kymera Therapeutics Inc EC | $6.85M | 4.23% |
| Celcuity Inc EC | $6.34M | 3.92% |
| Mirum Pharmaceuticals Inc EC | $6.31M | 3.90% |
| Spyre Therapeutics Inc EC | $5.95M | 3.68% |
| Cg Oncology Inc EC | $5.42M | 3.35% |
| Apogee Therapeutics Inc EC | $4.74M | 2.93% |
| Xenon Pharmaceuticals Inc EC | $4.69M | 2.90% |
| Travere Therapeutics Inc EC | $4.48M | 2.77% |
| Dianthus Therapeutics Inc EC | $4.26M | 2.64% |
| Newamsterdam Pharma Co Nv EC | $3.99M | 2.47% |
| Viking Therapeutics Inc EC | $3.9M | 2.41% |
| Crinetics Pharmaceuticals Inc EC | $3.84M | 2.37% |
| Acadia Pharmaceuticals Inc EC | $3.81M | 2.35% |
| Edgewise Therapeutics Inc EC | $3.78M | 2.33% |
| Denali Therapeutics Inc EC | $3.44M | 2.13% |
| Oruka Therapeutics Inc EC | $2.92M | 1.81% |
| Structure Therapeutics Inc EC | $2.87M | 1.78% |
| Disc Medicine Inc EC | $2.74M | 1.69% |
| Ideaya Biosciences Inc EC | $2.67M | 1.65% |
| Vera Therapeutics Inc EC | $2.61M | 1.61% |
| Tarsus Pharmaceuticals Inc EC | $2.61M | 1.61% |
| Relay Therapeutics Inc EC | $2.59M | 1.60% |
| Mineralys Therapeutics Inc EC | $2.57M | 1.59% |
| Celldex Therapeutics Inc EC | $2.16M | 1.33% |
| Zai Lab Ltd EC | $2.03M | 1.26% |
| Pharvaris Nv EC | $1.99M | 1.23% |
| Sionna Therapeutics Inc EC | $1.99M | 1.23% |
| Rapport Therapeutics Inc EC | $1.95M | 1.20% |
| Sarepta Therapeutics Inc EC | $1.93M | 1.20% |
| Lakefront Biotherapeutics Nv EC | $1.93M | 1.19% |
| Tyra Biosciences Inc EC | $1.85M | 1.15% |
| Novavax Inc EC | $1.84M | 1.14% |
| Stoke Therapeutics Inc EC | $1.82M | 1.12% |
| Agios Pharmaceuticals Inc EC | $1.78M | 1.10% |
| Vericel Corp EC | $1.74M | 1.08% |
| Nuvation Bio Inc EC | $1.71M | 1.06% |
| Palvella Therapeutics Inc EC | $1.67M | 1.03% |
| Taysha Gene Therapies Inc EC | $1.66M | 1.02% |
| Amylyx Pharmaceuticals Inc EC | $1.63M | 1.01% |
| Immatics Nv EC | $1.59M | 0.98% |
| Immunocore Holdings PLC EC | $1.51M | 0.93% |
| Mbx Biosciences Inc EC | $1.46M | 0.90% |
| Bicara Therapeutics Inc EC | $1.42M | 0.88% |
| Moonlake Immunotherapeutics EC | $1.42M | 0.88% |
| Kalvista Pharmaceuticals Inc EC | $1.4M | 0.87% |
| Arrivent Biopharma Inc EC | $1.38M | 0.85% |
| Oculis Holding Ag EC | $1.35M | 0.84% |
| Maze Therapeutics Inc EC | $1.31M | 0.81% |
| Mannkind Corp EC | $1.2M | 0.74% |
| Corvus Pharmaceuticals Inc EC | $1.07M | 0.66% |
| Olema Pharmaceuticals Inc EC | $1.07M | 0.66% |
| Zenas Biopharma Inc EC | $1.02M | 0.63% |
| Kura Oncology Inc EC | $929K | 0.57% |
| Ars Pharmaceuticals Inc EC | $928K | 0.57% |
| Xencor Inc EC | $898K | 0.56% |
| Theravance Biopharma Inc EC | $839K | 0.52% |
| Geron Corp EC | $825K | 0.51% |
| Design Therapeutics Inc EC | $666K | 0.41% |
| Alto Neuroscience Inc EC | $643K | 0.40% |
Showing top 60 of 89 holdings.
Loading...
